VALIANTLAB — Valiant Laboratories Share Price
Last trade - 00:00- IN₹5.90bn
- IN₹5.23bn
- IN₹1.82bn
- 41
- 10
- 25
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.59 | ||
| Price to Tang. Book | 2.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.37 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.3% | ||
| Return on Equity | 0.2% | ||
| Operating Margin | -5.69% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | n/a | 2,082.44 | 3,339.1 | 1,820.52 | n/a | n/a | -6.5% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -36.17 | -98.43 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Valiant Laboratories Limited is an India-based active pharmaceutical ingredient (API)manufacturing company. The Company is engaged in manufacturing and dealing in specialty chemicals and pharma intermediates in India and abroad. The Company is focused on manufacturing paracetamol API/bulk drug, which has various applications like uses in treatment of conditions, such as headache, muscle ache, arthritis, back ache, toothache, cold and fever. It operates in a single location manufacturing facility at Tarapur industrial estate. Its manufacturing facility is located at a distance of approximately 150 kilometers (km) from Nhava Sheva Port (JNPT). The Company’s subsidiary is VALIANT ADVANCED SCIENCES PRIVATE LIMITED.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- August 16th, 2021
- Public Since
- October 6th, 2023
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 43,450,000
- Address
- MUMBAI, 400080
- Web
- https://valiantlabs.in/
- Phone
- +91 2249712001
- Auditors
- Raman S. Shah
Similar to VALIANTLAB
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 23:57 UTC, shares in Valiant Laboratories are trading at IN₹141.19. This share price information is delayed by 15 minutes.
Shares in Valiant Laboratories last closed at IN₹141.19 and the price had moved by over the past 365 days. In terms of relative price strength the Valiant Laboratories share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Valiant Laboratories does not currently pay a dividend.
Valiant Laboratories does not currently pay a dividend.
Valiant Laboratories does not currently pay a dividend.
To buy shares in Valiant Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹141.19, shares in Valiant Laboratories had a market capitalisation of IN₹6.13bn.
Here are the trading details for Valiant Laboratories:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: VALIANTLAB
Based on an overall assessment of its quality, value and momentum Valiant Laboratories is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Valiant Laboratories. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -28.11%.
As of the last closing price of IN₹141.19, shares in Valiant Laboratories were trading -16.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Valiant Laboratories PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹141.19.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Valiant Laboratories' directors